Google Images |
Postdoctoral researcher Rebecca Leary and others, also from the John Hopkins University School of Medicine, have recently made an important observation: No matter what type of cancer is infecting an individual, tumor cells almost always have noticeably altered chromosomes such as swapped pieces or extra copies of genes. This discovery means that a test that could detect DNA abnormalities in the bloodstream has a promising possibility of becoming a general test used to detect cancer.
Different colors on the same chromosomes note abnormalities detectable by the blood test Image from ScienceNOW |
Although this is so far only applicable to advanced stages of cancer, they are hoping that once sequencing costs decrease they will be able to detect early stages of cancer in the bloodstream as well. The test is by no means cheap, with each test costing several thousand dollars just for the sequencing, and the analytic results would take at least a month to be returned. Researcher Victor Velculescu from the John Hopkins University School of Medicine in Maryland notes that, "As sequencing costs continue to drop in the very near future, this could end up being extremely cheap." Daniel Haber of Massachusetts General Hospital works on using circulating tumor cells to detect and monitor cancer said that, "The approach has tremendous promise and, should the sequencing strategy become economical, it could have important implications in early cancer detection."
Google Images |
Article: A Step Towards a Universal Cancer Blood Test
Written by: Jocelyn Kaiser
http://news.sciencemag.org/sciencenow/2012/11/a-step-toward-a-universal-cancer.html?ref=hp
No comments:
Post a Comment